Concepedia

Julie Lecuelle

JL

6

Publications

122

Citations

6

H-Index

2021

Active since

Affiliations

Université de Bourgogne(Current)

Inserm

Genomic and Immunotherapy Medical Institute

Centre Georges François Leclerc

Maison des Sciences sociales et des Humanités de Dijon

Julie Lecuelle is an author at Université de Bourgogne specializing in oncology, tumor microenvironment, and immunology.

ORCID

Top concepts

Publications per year

2021–2022

6

Publications

6

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer

Loïck Galland, Julie Lecuelle, Laure Favier et al. · Cancers · 2021 · 27 citations · Full text

Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1

Loïck Galland, Anne Laure Le Page, Julie Lecuelle et al. · OncoImmunology · 2021 · 27 citations · Full text

, , +16

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing

Loïck Galland, Elise Ballot, Hugo Mananet et al. · npj Breast Cancer · 2022 · 24 citations · Full text

MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer

Julie Lecuelle, Laure Favier, Cléa Fraisse et al. · Journal for ImmunoTherapy of Cancer · 2022 · 19 citations · Full text

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer

Valentin Dérangère, Julie Lecuelle, Côme Lepage et al. · European Journal of Cancer · 2022 · 15 citations

, , +8

Rows per page

1–5 of 6